Platform
Features
0 followers
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.
Industries
Headquarters
Stage
Employees
Links
Niels C. Riedemann
7 members
5 members
4 members
3 members
BioNTech
10 followers
QIAGEN
8 followers
Forge Biologics
2 followers
Immunome
Neogene Therapeutics
PepGen
Centogene
1 follower
Cellares
Thermo Fisher Scientific
141 followers
Gilead Sciences
119 followers
Vertex Pharmaceuticals
50 followers
Discover companies